Rev Genomics
Rev is a biotechnology company creating better plants.
What Rev Genomics does
Rev Genomics is a plant biotechnology company that provides breeders, growers, and retailers with novel cultivars to differentiate themselves in high value markets.
1 open role
What the role involves
Rev Genomics seeks a versatile PhD for an open scientist position. Plant biologists will be given top priority. The position comes with competitive salary, stock options, and a health-care plan. Rev is a biotechnology company that focuses on creating better plants. In particular, we focus on cannabis. Top candidates should have the following experience and training: • PhD in plant biology or a related discipline (open to recent grads as well as those with industry experience) • Deep expertise in plant tissue culture, with experience with plant transformation highly desirable • Excellent molecular biology skills • Exposure to bio-informatics highly desirable Essentially, if you can take a project from conception, through construct creation, to plant transformation, to regeneration, you might be the perfect candidate. Other highly desirable skills include: • Excellent work ethic. This is a start-up, and there aren’t many 40-hour weeks. • Demonstrated ability to work as part of a team. In other words, personality matters. • Great attention to detail and well-developed organizational skills. • Flexibility. We are looking to fill this position ASAP, but we do have some flexibility with your start date.
Roles are as last read from the company’s own listings. Openings close without notice — check the date on the listing before you spend an evening on the application.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Rev Genomics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.